Company
Janssen Biotech, Inc.
20 Case(s) (Last 5 Years)
Patents Prosecuted
| Application number | Title of the patent | IPC | Filing Date | Decision Date |
|---|---|---|---|---|
| 18483270 | HUMAN ANTIBODY SPECIFIC FOR INTERLEUKIN-1ALPHA | C07K, G01N, C12N | Oct 8, 2023 | |
| 18478374 | TREATMENT OF HIDRADENITIS SUPPURATIVA | A61P, C07K | Sep 28, 2023 | |
| 18461191 | MATERIALS AND METHODS FOR IMPROVED SINGLE CHAIN VARIABLE FRAGMENTS | C07K | Sep 4, 2023 | |
| 18452751 | APPROVED PRODUCTS FOR THE TREATMENT OF MULTIPLE MYELOMA | A61K, A61P, C07K | Aug 20, 2023 | |
| 18344973 | MATERIALS AND METHODS FOR BIOENGINEERED IPSC POPULATIONS | C12N | Jun 29, 2023 | |
| 18210821 | DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS | C12N, A61K | Jun 15, 2023 | |
| 18300683 | Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Pomalidomide and Dexamethasone | A61K, C07K, A61P | Apr 13, 2023 | |
| 18300183 | Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib, Mephalan and Prednisone | A61P, A61K | Apr 12, 2023 | |
| 18175347 | BCMA-TARGETED CAR-T CELL THERAPY FOR MULTIPLE MYELOMA | A61K, A61P | Feb 26, 2023 | |
| 18166878 | Safe and Effective Method of Treating Psoriatic Arthritis with Anti-IL23 Specific Antibody | C07K, A61P | Feb 8, 2023 | |
| 18100056 | Use of Approved Anti-CD38 Antibody Drug Product in Combination with Pomalidomide and Dexamethasone to Treat Multiple Myeloma | G06Q, A61P, A61K | Jan 22, 2023 | |
| 18099852 | METHODS FOR MAKING INSULIN IN VIVO | C12N | Jan 19, 2023 | |
| 18080639 | VACCINES BASED ON MUTANT CALR AND JAK2 AND THEIR USES | A61K | Dec 12, 2022 | |
| 18080634 | PROSTATE CANCER VACCINES AND USES THEREOF | A61K, A61P | Dec 12, 2022 | |
| 17990887 | METHODS FOR DETERMINATION OF VIRUS TITER IN A SAMPLE USING RAMAN SPECTROSCOPY | G01N, G01J | Nov 20, 2022 | |
| 17988910 | FEEDER FREE CELL CULTURE METHODS FOR EXPANDING NATURAL KILLER CELL PREPARATIONS | A61P, A61K, C12N | Nov 16, 2022 | |
| 18054372 | Method for determining severity of skin disease based on percentage of body surface area covered by lesions | G06T | Nov 9, 2022 | Feb 26, 2024 |
| 18053904 | STABLE FORMULATIONS COMPRISING A BISPECIFIC BCMA/CD3 ANTIBODY | A61K, C07K | Nov 8, 2022 | |
| 18052349 | BCMA-TARGETED CAR-T CELL THERAPY FOR MULTIPLE MYELOMA | A61K, C07K, A61P | Nov 2, 2022 | |
| 17980149 | Corticosteriod Reduction in Treatment with Anti-CD38 Antibody | A61K, A61P, C07K | Nov 2, 2022 |